# FDA Inspection 1120549 - North Shore University Hospital Northwell Health - March 12, 2020

Source: https://www.keypedia.com/records/fda_inspections/north-shore-university-hospital-northwell-health/20c2e5ab-43db-44cf-839f-e5da08269cbf
Source feed: FDA_Inspections

> FDA Inspection 1120549 for North Shore University Hospital Northwell Health on March 12, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120549
- Company Name: North Shore University Hospital Northwell Health
- Inspection Date: 2020-03-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1306816 - 2026-03-11](https://www.keypedia.com/records/fda_inspections/north-shore-university-hospital-northwell-health/1714ef33-f270-4630-ab1e-a50de193f782)
- [FDA Inspection 1307150 - 2026-03-04](https://www.keypedia.com/records/fda_inspections/north-shore-university-hospital-northwell-health/1ad9d199-eb9f-49c0-b826-4a13e7f5c9e8)
- [FDA Inspection 1241373 - 2024-06-12](https://www.keypedia.com/records/fda_inspections/north-shore-university-hospital-northwell-health/4d9969c8-929d-4707-a93f-dddbe7fd834f)
- [FDA Inspection 1203742 - 2023-04-26](https://www.keypedia.com/records/fda_inspections/north-shore-university-hospital-northwell-health/89b9fdb0-af90-46c5-b417-dd0323d2d0d5)
- [FDA Inspection 1174916 - 2022-07-20](https://www.keypedia.com/records/fda_inspections/north-shore-university-hospital-northwell-health/4155931c-ee4e-4ff7-96d5-1ea203595cae)

Company: https://www.keypedia.com/companies/north-shore-university-hospital-northwell-health/9240ff8d-1ae6-48bf-a7e5-6dd4ec0f267f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d